Stock Markets June 18, 2026 05:47 PM

Akanda Shares Plunge After Nasdaq Flags Equity Shortfall

Cannabis company moves to file compliance plan after Nasdaq cites deficiency in stockholders' equity and alternative listing standards

By Jordan Park
Share
Twitter Reddit Facebook LinkedIn
AKAN

Akanda Corp.'s stock dropped sharply in after-hours trading after the company disclosed receipt of a Nasdaq deficiency notice citing a shortfall in required stockholders' equity and failure to meet alternative continued listing standards. The company reported negative stockholders' equity for fiscal 2025 and has until July 31, 2026 to submit a plan to regain compliance.

Akanda Shares Plunge After Nasdaq Flags Equity Shortfall
AKAN
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Nasdaq notified Akanda on June 16, 2026 of non-compliance with Listing Rule 5550(b)(1), which requires at least $2.5 million in stockholders' equity for companies on The Nasdaq Capital Market.
  • Akanda reported negative stockholders' equity of $11,990,437 for the fiscal year ended December 31, 2025 and also fails to meet alternative Nasdaq continued listing standards related to market value of listed securities and net income from continuing operations.
  • The company has 45 calendar days, until July 31, 2026, to submit a plan to regain compliance; Nasdaq may grant an extension of up to 180 calendar days from the notice date if it accepts the plan.

Akanda Corp. experienced a steep decline in its share price in after-hours trading, tumbling 18% following a public disclosure that Nasdaq has issued a deficiency notice related to the company's stockholders' equity.

Nasdaq notified Akanda on June 16, 2026 that the company is not in compliance with Listing Rule 5550(b)(1). That rule requires issuers on The Nasdaq Capital Market to maintain at least $2.5 million in stockholders' equity to remain eligible for listing.

Akanda's latest Annual Report on Form 20-F for the fiscal year ended December 31, 2025 documents the company's stockholders' equity as negative $11,990,437. In addition to the equity shortfall, Nasdaq determined that Akanda does not meet alternative continued listing requirements tied to market value of listed securities or to net income from continuing operations.

The notice from Nasdaq does not immediately remove Akanda's common shares from The Nasdaq Capital Market. Under applicable Nasdaq procedures, the company has 45 calendar days from the notice date to file a plan describing how it will regain compliance - a deadline that falls on July 31, 2026. If Nasdaq accepts the submitted plan, it may provide an extension of up to 180 calendar days measured from the date of the notice, during which the company would be expected to become compliant.

In response to the notice, Akanda said it intends to submit a compliance plan within the stated timeframe and is evaluating various alternatives to return to compliance with Nasdaq's listing standards. The company did not provide further detail on the specific actions it is considering.

Investors reacted quickly to the disclosure, with the company's shares sliding in extended trading. The Nasdaq notice centers on clearly defined numerical thresholds and alternate tests for continued listing, and Akanda's reported negative equity figure is the specific basis cited in the deficiency letter.

This development places the company into a formal compliance review process under Nasdaq rules. Akanda now faces a choice of filing a plan that Nasdaq accepts or pursuing other measures to address the equity deficit and the alternative standards it has failed to meet.


Summary

Akanda received a Nasdaq deficiency notice dated June 16, 2026 for failing to meet the $2.5 million stockholders' equity requirement under Listing Rule 5550(b)(1). The company reported negative $11,990,437 in stockholders' equity for the fiscal year ended December 31, 2025, and also does not meet Nasdaq's alternative continued listing standards. Akanda has until July 31, 2026 to submit a compliance plan and said it intends to do so while evaluating options to regain compliance.

Risks

  • Uncertainty over whether Nasdaq will accept Akanda's compliance plan and whether an extension will be granted - this affects the company's continued listing status.
  • The company's reported negative $11,990,437 in stockholders' equity and failure to meet alternative listing standards create ongoing compliance risk for Akanda and raise investor uncertainty in the cannabis sector.
  • Share price volatility following the disclosure - evidenced by an 18% after-hours drop - may impact liquidity and investor confidence for Akanda shares in the near term.

More from Stock Markets

Appeals Court Clears Path for Ohio Law Requiring Parental Consent for Under-16 Social Media Users Jun 18, 2026 Intel Elevates Seok-Hee Lee to Drive Advanced Packaging and Back-End Manufacturing Jun 18, 2026 BTQ Technologies shares slip after C$150M at-the-market equity program announced Jun 18, 2026 Team Inc Names New CFO as Shares Slip in After-Hours Trading Jun 18, 2026 Standard Nuclear Seeks NYSE Listing to Scale TRISO Fuel Production Jun 18, 2026